---
schema_version: "secwatch.filing_event.v1"
accession: "0001639691-22-000088"
form_type: "8-K"
ticker: "LIVN"
cik: "0001639691"
company_name: "LivaNova PLC"
filed_at: "2022-09-15T23:59:59+00:00"
generated_at: "2026-06-23T09:25:28.525550+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# LivaNova appoints Brooke Story to Board of Directors effective Sept 15, 2022

## Summary
- Brooke Story appointed to LivaNova Board, brings over 20 years in medtech; currently Worldwide President at BD.
- Story previously held leadership roles at Medtronic, including President of Pelvic Health and Gastric Therapies.
- She will receive a prorated annual board retainer of $110,000, NG committee fee of $8,000, and $130,000 RSU grant.
- No arrangement or related-party transactions exist between Story and LivaNova.
- Story fills a board vacancy; compensation consistent with company's Remuneration Policy for non-employee directors.

## SEC filing metadata
- accession: 0001639691-22-000088
- form_type: 8-K
- ticker: LIVN
- cik: 0001639691
- company_name: LivaNova PLC
- filed_at: 2022-09-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1639691/000163969122000088/0001639691-22-000088-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1639691/000163969122000088/livn-20220915.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001639691-22-000088
- JSON: https://secwatch.observer/filing/0001639691-22-000088.json
- Plain text: https://secwatch.observer/filing/0001639691-22-000088.txt

## Key facts
- Executive change
  Brooke Story was appointed as Director at LivaNova PLC.
  - Action: appointed
  - Role: Director
  source text: On September 15, 2022, the Board of Directors (the “Board”) of LivaNova PLC (the “Company” or “LivaNova”) appointed Brooke Story to the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1639691/000163969122000088/0001639691-22-000088-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.